**6. Pathology**

The past 20 years have seen major advances in the understanding of the effects of antidonor antibodies on renal allografts at various stages after transplantation. These advan‐ ces have been due in large part to pathologic examination of both early and late renal allograft biopsies, including both routine histologic evaluation and immunohistology to detect complement split products.
